POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED) Pharmacologic Class Indexing
- Class set ID
- 27ba957a-e26e-4f8b-8f1b-d15e32b4a886
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use KINRIX safely and effectively. See full prescribing information for KINRIX. KINRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine) injectable suspension, for intramuscular use Initial U.S. Approval: 2008 | GlaxoSmithKline Biologicals SA | 20260514 | 32 |
| These highlights do not include all the information needed to use PEDIARIX safely and effectively. See full prescribing information for PEDIARIX. PEDIARIX [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine] injectable suspension, for intramuscular use Initial U.S. Approval: 2002 | GlaxoSmithKline Biologicals SA | 20260514 | 30 |
| These highlights do not include all the information needed to use Pentacel safely and effectively. See full prescribing information for Pentacel. Pentacel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine for injectable suspension, for intramuscular use Initial U.S. Approval: 2008 | Sanofi Vaccines US Inc. | Sanofi Vaccines Canada Ltd. | 20260428 | 13 |
| These highlights do not include all the information needed to use VAXELIS safely and effectively. See full prescribing information for VAXELIS. VAXELIS ® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) injectable suspension, for intramuscular use Initial U.S. Approval: 2018 | MSP Vaccine Company | Sanofi Vaccines Canada Ltd. | Sanofi Winthrop Industrie | Merck Sharp & Dohme Corp. | 20260428 | 14 |
| These highlights do not include all the information needed to use Quadracel safely and effectively. See full prescribing information for Quadracel. Quadracel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine) injectable suspension, for intramuscular use Initial U.S. Approval: 2015 | Sanofi Vaccines US Inc. | Sanofi Vaccines Canada Ltd. | 20260427 | 10 |
| Poliovirus Vaccine Inactivated IPOL ® | Sanofi Pasteur Inc. | Sanofi Winthrop Industrie | 20260130 | 13 |
| These highlights do not include all the information needed to use PEDIARIX safely and effectively. See full prescribing information for PEDIARIX. PEDIARIX [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine], Suspension for Intramuscular Injection Initial U.S. Approval: 2002 | A-S Medication Solutions | 20250813 | 2 |
| These highlights do not include all the information needed to use Pentacel safely and effectively. See full prescribing information for Pentacel. Pentacel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine Suspension for Intramuscular Injection Initial U.S. Approval: 2008 | A-S Medication Solutions | 20250516 | 1 |
| These highlights do not include all the information needed to use VAXELIS safely and effectively. See full prescribing information for VAXELIS. VAXELIS ® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) Suspension for Intramuscular Injection Initial U.S. Approval: 2018 | A-S Medication Solutions | 20250513 | 1 |
| IPOL | A-S Medication Solutions | 20241104 | 19 |